Literature DB >> 25470637

Recent advances in understanding the role of oxidative stress in diabetic neuropathy.

Manal Shakeel1.   

Abstract

Diabetic neuropathy (DN) is one of the most common and severe manifestations of diabetes mellitus. The mechanisms underlying the structural, functional and metabolic changes in diabetic neuropathy have been under study for a long time. In this review the biochemistry and implications of the four pathways responsible for the development of DN, polyol pathway; increased AGEs (advanced glycation end-products) formation; activation of PKC (protein kinase C) and hexosamine pathway have been discussed. Experimental and clinical evidences suggest a close link between neurodegeneration and oxidative stress which serves as a unifying mechanism, thus linking the four pathways. Recent studies indicate that oxidative stress mediated DNA damage causes poly(ADP-ribose) polymerase (PARP) overactivation and reduced activity of glyceraldehyde 3-phosphate dehydrogenase (GAPDH), a factor common to all the four pathways. The exact mechanism of PARP mediated cell death in DN needs further investigation. Based on current studies neuroprotective and antioxidant therapy have been suggested as potential treatment and preventive solutions for DN.
Copyright © 2014 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diabetic neuropathy; Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) inhibition; Neurodegeneration; Oxidative stress; Poly(ADP-ribose) polymerase (PARP) overactivation

Mesh:

Substances:

Year:  2014        PMID: 25470637     DOI: 10.1016/j.dsx.2014.04.029

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  17 in total

1.  Triglyceride-lowering effect of the aldose reductase inhibitor cemtirestat-another factor that may contribute to attenuation of symptoms of peripheral neuropathy in STZ-diabetic rats.

Authors:  Marta Soltesova Prnova; Lucia Kovacikova; Karol Svik; Stefan Bezek; Zübeyir Elmazoğlu; Cimen Karasu; Milan Stefek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-12-05       Impact factor: 3.000

Review 2.  Nrf2: a potential therapeutic target for diabetic neuropathy.

Authors:  Anil Kumar; Ruchika Mittal
Journal:  Inflammopharmacology       Date:  2017-03-28       Impact factor: 4.473

3.  Chronic kidney disease and peripheral nerve function in the Health, Aging and Body Composition Study.

Authors:  Ranjani N Moorthi; Simit Doshi; Linda F Fried; Sharon M Moe; Mark J Sarnak; Suzanne Satterfield; Ann V Schwartz; Michael Shlipak; Brittney S Lange-Maia; Tamara B Harris; Anne B Newman; Elsa S Strotmeyer
Journal:  Nephrol Dial Transplant       Date:  2019-04-01       Impact factor: 5.992

4.  Pyruvate Dehydrogenase Kinase-mediated Glycolytic Metabolic Shift in the Dorsal Root Ganglion Drives Painful Diabetic Neuropathy.

Authors:  Md Habibur Rahman; Mithilesh Kumar Jha; Jong-Heon Kim; Youngpyo Nam; Maan Gee Lee; Younghoon Go; Robert A Harris; Dong Ho Park; Hyun Kook; In-Kyu Lee; Kyoungho Suk
Journal:  J Biol Chem       Date:  2016-01-14       Impact factor: 5.157

Review 5.  Activation of Nrf2 signaling by natural products-can it alleviate diabetes?

Authors:  Manuel Matzinger; Katrin Fischhuber; Elke H Heiss
Journal:  Biotechnol Adv       Date:  2017-12-28       Impact factor: 14.227

Review 6.  Gut microbiota-derived short-chain fatty acids and kidney diseases.

Authors:  Lingzhi Li; Liang Ma; Ping Fu
Journal:  Drug Des Devel Ther       Date:  2017-12-11       Impact factor: 4.162

Review 7.  Interactions between and Shared Molecular Mechanisms of Diabetic Peripheral Neuropathy and Obstructive Sleep Apnea in Type 2 Diabetes Patients.

Authors:  Hong Shen; Junrong Zhao; Ying Liu; Guangdong Sun
Journal:  J Diabetes Res       Date:  2018-07-19       Impact factor: 4.011

8.  Lipoic Acid Decreases the Expression of Poly ADP-Ribose Polymerase and Inhibits Apoptosis in Diabetic Rats.

Authors:  Jingfang Chen; Qiang Li
Journal:  Diabetes Metab Syndr Obes       Date:  2020-05-20       Impact factor: 3.168

9.  Non-Targeted Metabolomic Analysis Reveals Serum Phospholipid Alterations in Patients with Early Stages of Diabetic Foot Ulcer.

Authors:  Ignacio I Álvarez-Rodríguez; Eduardo Castaño-Tostado; David G García-Gutiérrez; Rosalía Reynoso-Camacho; Juana E Elton-Puente; Alicia Barajas-Pozos; Iza F Pérez-Ramírez
Journal:  Biomark Insights       Date:  2020-09-09

10.  Antioxidant SMe1EC2 modulates pentose phosphate pathway and glutathione-dependent enzyme activities in tissues of aged diabetic rats.

Authors:  Nuray Nuriye Ulusu; Müslüm Gök; Arzu Ayşe Sayin Şakul; Nuray Ari; Milan Stefek; Çimen Karasu
Journal:  Interdiscip Toxicol       Date:  2018-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.